BILL ANALYSIS �
------------------------------------------------------------
|SENATE RULES COMMITTEE | SCR 91|
|Office of Senate Floor Analyses | |
|1020 N Street, Suite 524 | |
|(916) 651-1520 Fax: (916) | |
|327-4478 | |
------------------------------------------------------------
THIRD READING
Bill No: SCR 91
Author: Runner (R), et al.
Amended: As introduced
Vote: 21
SUBJECT : Scleroderma Awareness Month
SOURCE : Scleroderma Foundation
DIGEST : This resolution proclaims June 2012 as
Scleroderma Awareness Month.
ANALYSIS : This resolution makes the following
legislative findings:
1. Scleroderma is a chronic, disabling autoimmune
disease in which the body's soft tissues contract and
harden from an overproduction of collagen.
2. Scleroderma can affect many parts of the body
including skin, internal organs, and blood vessels.
3. Scleroderma sufferers often experience damage to the
heart, lungs, kidneys, and the gastrointestinal tract.
4. Scleroderma is associated with many other conditions
including pulmonary hypertension, gastroparesis,
Raynaud's phenomenon, Sj�gren's syndrome, and lupus.
5. Choctaw Native Americans, African Americans, and
Hispanics are disproportionately affected by
CONTINUED
SCR 91
Page
2
scleroderma.
6. Researchers have yet to identify the exact cause or
causes of scleroderma.
7. An estimated 300,000 Americans suffer from
scleroderma, and 80 percent of those are women.
8. The estimated total economic impact of scleroderma
treatment is estimated to be in excess of $1.5 billion
annually.
9. There is a significant need for further research
focusing on the epidemiology of scleroderma to increase
understanding of the causes of the disease and its
treatment.
10. The United States Congress has recognized the need to
raise awareness of the impact of scleroderma on public
health and has designated June as National Scleroderma
Awareness Month.
11. California should also designate a month as
Scleroderma Awareness Month to help educate the public
about autoimmune diseases and the need for increased
research, funding, and effective treatments for those
diseases.
12. The designation of such a month would recognize the
efforts of health care providers, patients, and
scleroderma advocacy organizations to raise awareness
of scleroderma and of the need for increased research
on scleroderma.
13. June 2012 would be an appropriate month to designate
as Scleroderma Awareness Month.
This resolution proclaims June 2012 as Scleroderma
Awareness Month.
FISCAL EFFECT : Fiscal Com.: No
SUPPORT : (Verified 6/7/10)
SCR 91
Page
3
Scleroderma Foundation (source)
CTW:nl 6/7/12 Senate Floor Analyses
SUPPORT/OPPOSITION: SEE ABOVE
**** END ****